All lobbying filings

Monument Advocacy

Monument Advocacy filed a Q3 report for Boehringer Ingelheim USA Corporation on October 20, 2026, reporting $50,000 in lobbying income.

Lobbying for Boehringer Ingelheim USA Corporation · Pharmaceutical company

As filed: MONUMENT ADVOCACY for BOEHRINGER INGELHEIM USA CORPORATION.

All filings by Monument Advocacy · Everything Boehringer Ingelheim USA Corporation has reported

Filing · LD-2 quarterly report Q3 report

Reporting period

3rd Quarter 2026

July 1 - Sep 30 · Posted Oct 20, 2026

Income

$50,000

What the client paid this registrant for the period.

Client based in

Connecticut

Official filing document

Government bodies contacted 3

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 2

Agriculture

Issues related to general agriculture, animal health, foreign animal disease, regulatory processes, USDA Programs, the farm bill incl HR 7567 + S5526, wildlife services, oral rabies vaccination program, and national vaccine banks.

Budget/Appropriations

Issues related to FY27 agricultural appropriations including HR8646

Bills named in this filing 2

H.R. 7567
Farm, Food, and National Security Act of 2026
H.R. 8646
Agriculture, Rural Development, Food and Drug Administration, and Related Agency Appropriations Act, 2027

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.